Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinoma Cells

PDAC (pancreatic ductal adenocarcinoma) is a highly aggressive malignant tumor. We have previously developed induced tumor-suppressing cells (iTSCs) that secrete a group of tumor-suppressing proteins. Here, we examined a unique procedure to identify anticancer peptides (ACPs), using trypsin-digested...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Changpeng, Huo, Qingji, Xiong, Xue, Li, Kexin, Fishel, Melissa L., Li, Baiyan, Yokota, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610494/
https://www.ncbi.nlm.nih.gov/pubmed/37896207
http://dx.doi.org/10.3390/pharmaceutics15102447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610494/
https://www.ncbi.nlm.nih.gov/pubmed/37896207
http://dx.doi.org/10.3390/pharmaceutics15102447

Ejemplares similares